Summary & Overview
CPT 84375: Chromatographic Urine Sugar Detection
CPT code 84375 represents a laboratory procedure to detect sugars using chromatographic methods such as thin layer chromatography (TLC) or paper chromatography, most commonly performed on urine specimens. This code matters nationally because it documents a specialized qualitative laboratory service used in metabolic screening, toxicology workups, and certain diagnostic evaluations where identification of sugars or carbohydrate derivatives is clinically relevant. Accurate coding of this service supports appropriate claims processing, clinical recordkeeping, and surveillance of laboratory utilization.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for the test, typical sites of service, and payer coverage considerations. The publication summarizes common billing and coding themes, highlights where policy updates may affect reimbursement recognition, and situates 84375 within laboratory service lines. Practical benchmarking and payer-specific policy language are included where available. Data not provided in the input is noted where relevant. The content is intended to inform coding staff, laboratory managers, and policy analysts about the clinical purpose and billing context for CPT code 84375 on a national level.
Billing Code Overview
CPT code 84375 describes a laboratory test that detects the presence of sugars by chromatographic methods, including thin layer chromatography (TLC) or paper chromatography. The test is typically performed on urine specimens and is used to identify or screen for carbohydrate compounds that may have clinical relevance.
Service Type: Laboratory — qualitative/identification test using chromatographic methods
Typical Site of Service: Clinical laboratory or hospital laboratory
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult or pediatric outpatient presenting for evaluation of glycosuria or suspected ingestion of non-glucose sugars (for example, pentoses, reducing sugars, or certain medication metabolites). The clinician collects a random or timed urine specimen during a clinic, emergency department, or outpatient laboratory visit. The laboratory performs a chromatographic sugar screen such as thin layer chromatography (TLC) or paper chromatography to detect the presence and pattern of reducing sugars when routine urine dipstick or enzymatic glucose assays are inconclusive or when a specific non-glucose sugar ingestion is suspected. Results are reported to the ordering provider, who integrates findings with clinical history (medication exposure, dietary intake, signs of inborn errors of metabolism, or intoxication) to guide further testing or management. Typical site of service is an outpatient clinical laboratory, hospital laboratory, or community clinic with laboratory capabilities.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | General default when no specific modifier applies |
11 | Office or other outpatient service; typically primary procedure |